About Index Trending news
Lists
Pricing
STENTYS

STENTYS

STENTYS

STENTYS products treat patients with AMI and complex coronary disease where a vessel size is ambiguous: the Self-Apposing STENTYS BMS and DES and the STENTYS AC

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO equity
$13,400,000
Employees

Team size

10+
Locations
HQ
Headquarters
$13,400,000 Post-IPO equity
MassDevice

Stentys raises $13.9m to fund Euro expansion